• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

15 Key Women’s Health Investment Opportunities in 2025

By Kathrin Folkendt Ecosystem, News, Opinion, Trend Watch January 8, 2025
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Maternal Health, News, Pregnancy, Research October 9, 2023
$50 Million NIH Grant Funds CHOP and Penn Medicine Research on Environmental Impact on Pregnancy and Child Health
Maternal Health, News August 23, 2022
Maternal Health Startup Delfina Joins UnitedHealthcare Accelerator
Written By
Kathrin Folkendt

Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.

Recent Posts
  • JAMA Launches Dedicated Women’s Health Channel to Address Research and Evidence Gaps
  • Innovation Finally Addresses Pregnancy Loss: From Digital Support to Diagnostic Breakthroughs
  • BoobyBiome Raises £2.5M to Preserve Breast Milk’s Hidden Microbiome
  • Zepp Health Acquires Wild.AI Assets to Integrate Hormone-Informed Coaching into Amazfit Devices
  • FDA Approves Henlius-Organon Denosumab Biosimilars for Osteoporosis and Bone Cancer Treatment

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2025. All rights reserved.